ADVFN - ニュース

S&P 500

5,464.62

-0.16%

登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

登録

銘柄名/コード:

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/06/22	05 : 19	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	NYSE:GS-J	Goldman Sachs Group Inc
2024/06/22	05 : 19	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	AMEX:AMJ	JP Morgan Alerian MLP
2024/06/22	05 : 18	Edgar (US Regulatory)	Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses	USOTC:BMOLF	Bank of Montreal (PK)
2024/06/22	05 : 18	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	USOTC:BMOLF	Bank of Montreal (PK)
2024/06/22	05 : 17	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	AMEX:AMJ	JP Morgan Alerian MLP
2024/06/22	05 : 17	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	AMEX:FBGX	UBS AG FI Enhanced Large Cap Growth
2024/06/22	05 : 17	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	AMEX:FBGX	UBS AG FI Enhanced Large Cap Growth
2024/06/22	05 : 17	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	AMEX:FBGX	UBS AG FI Enhanced Large Cap Growth
2024/06/22	05 : 17	Edgar (US Regulatory)	Form 424B1 - Prospectus [Rule 424(b)(1)]	NASDAQ:ERESU	East Resources Acquisition Company
2024/06/22	05 : 17	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	AMEX:FBGX	UBS AG FI Enhanced Large Cap Growth
2024/06/22	05 : 17	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	AMEX:FBGX	UBS AG FI Enhanced Large Cap Growth
2024/06/22	05 : 17	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	AMEX:FBGX	UBS AG FI Enhanced Large Cap Growth
2024/06/22	05 : 16	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	AMEX:FBGX	UBS AG FI Enhanced Large Cap Growth
2024/06/22	05 : 16	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	AMEX:FBGX	UBS AG FI Enhanced Large Cap Growth
2024/06/22	05 : 16	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	AMEX:FBGX	UBS AG FI Enhanced Large Cap Growth
2024/06/22	05 : 16	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	AMEX:FBGX	UBS AG FI Enhanced Large Cap Growth
2024/06/22	05 : 15	GlobeNewswire Inc.	Thunder Power Holdings, Inc. Announces Consummation of Business Combination and Commencement of Trading on Nasdaq	NASDAQ:FLFV	Feutune Light Acquisition Corporation
2024/06/22	05 : 15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:FREQ	Frequency Therapeutics Inc
2024/06/22	05 : 15	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	AMEX:FBGX	UBS AG FI Enhanced Large Cap Growth
2024/06/22	05 : 15	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	AMEX:FBGX	UBS AG FI Enhanced Large Cap Growth
2024/06/22	05 : 15	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	AMEX:FBGX	UBS AG FI Enhanced Large Cap Growth
2024/06/22	05 : 15	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	AMEX:FBGX	UBS AG FI Enhanced Large Cap Growth
2024/06/22	05 : 15	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	NYSE:GS-J	Goldman Sachs Group Inc
2024/06/22	05 : 15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:LGSTU	Semper Paratus Acquisition Coporation
2024/06/22	05 : 15	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	AMEX:FBGX	UBS AG FI Enhanced Large Cap Growth
2024/06/22	05 : 15	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	AMEX:FBGX	UBS AG FI Enhanced Large Cap Growth
2024/06/22	05 : 15	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:GIAF	GigCapital 5 Inc (PK)
2024/06/22	05 : 15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:DUNEU	Dune Acquisition Corporation
2024/06/22	05 : 15	GlobeNewswire Inc.	Norwood Financial Corp Announces Appointment of John M. McCaffery as Executive Vice President and Chief Financial Officer	NASDAQ:NWFL	Norwood Financial Corporation
2024/06/22	05 : 15	Business Wire	BioAge Labs Presents Preclinical Data for Apelin Receptor Agonist Azelaprag for Obesity Demonstrating Significant Improvements in Weight Loss and Body Composition When Combined with Incretin Drugs